Daily TIP

The Daily TIP: Hebrew U Student Wins Award for Breakthrough in Detecting Parkinson’s Disease

Posted by Tip Staff - July 06, 2017

Hebrew U Student Wins Award for Breakthrough in Detecting Parkinson’s Disease
London Mayor Calls for Total Ban on Hezbollah
New York Times Calls Palestinian Terrorist Convicted of Five Murders a “Freedom Fighter”
Foundation Invests $7 Million in 8 Joint U.S.-Israel Business Ventures< /strong>

Hebrew U Student Wins Award for Breakthrough in Detecting Parkinson’s Disease

A PhD student has won an award for developing a test that could revolutionize the detection of Parkinson's disease in patients, especially in its early stages, Hebrew University announced on Wednesday.

The university awarded the Kaye Innovation Award to Suaad Abd-Elhadi for developing a diagnostic approach for detecting a specific protein, alpha-synuclein, whose presence is associated with tissues affected by Parkison's disease.

Parkinson's is the second most common neurodegenerative disease in humans after Alzheimer's disease. Usually it is detected by motor control symptoms such as tremors and shaking. It also can have effects on behavior and cognitive ability.

According to the announcement, the test developed by Abd-Elhadi, who is working towards her PhD in the Department of Biochemistry and Molecular Biology at Hebrew University's medical school, "could lead to earlier detection of Parkinson’s, along with better tracking of the disease’s progression and a patient’s response to therapy."

The Kaye Innovation Award was instituted in 1994 by Isaac Kaye, a resident of the United Kingdom, who is a giant in the healthcare industry, to encourage Hebrew University students and faculty to innovate and come up with inventions that "have good commercial potential."

Abd-Elhadi's research has been conducted under the supervision of Dr. Ronit Sharon. Yissum, Hebrew University's technology transfer company has signed an agreement for further development and commercialization of the test.

London Mayor Calls for Total Ban on Hezbollah

London mayor Sadiq Khan has called on UK Home Secretary Amber Rudd to outlaw Hezbollah’s political and military wing, after flags of the terror group were openly flown during al-Quds Day in the capital last month, The Times of Israel reported Thursday.

During the rally, children were draped in Hezbollah flags and organizers distributed placards emblazoned with the slogan, “We are all Hezbollah.” The marchers chanted “From the river to the sea," a chant calling for the elimination of the Jewish state.

The so-called military wing of Hezbollah has been proscribed by the British government, but attempts by figures from across the political spectrum to have the political wing of the organization banned have so far failed. Hezbollah---whose own leaders acknowledge that there is no distinction between their political and military branches---is banned in full by the U.S., Canada, and the Arab League.

Conservative London assembly member Andrew Boff, who repeatedly urged Khan to write to the Home Secretary to have Hezbollah banned, welcomed the decision but questioned why it took authorities so long to act.

“We welcome news that the mayor has finally been pressured into taking action against this appalling anti-Semitic organisation but why has it taken him weeks to do so?” Boff said. “He is taking action now because he was asked again by a member of his own party and is under pressure to act,” he added.

New York Times Calls Palestinian Terrorist Convicted of Five Murders a “Freedom Fighter”

The New York Times published an article on Wednesday profiling Fadwa Barghouti, the wife of Marwan Barghouti, a Palestinian terrorist currently serving five consecutive life terms in an Israeli prison for murder.

Written by Shaina Shealy, the article warmly portrays Fadwa as a champion for her husband’s freedom, notably failing to mention that she also participated in a 2015 march in honor of Abu Jihad, a lieutenant of Yasser Arafat who was implicated in 125 murders.

“He led, she says, but he never killed,” Shealy wrote of Fadwa. Fadwa’s attempted defense paradoxically bolstered Israel’s case that Marwan orchestrated terrorist attacks that claimed hundreds of lives. During interrogation, Marwan admitted that this was his role.

Marwan was convicted by a civilian court in May 2004 of involvement in three terrorist attacks in Israel that killed five people. He was acquitted on charges of 33 other murders due to lack of evidence of direct involvement.

Despite this, the Times article still described Marwan as a “Palestinian political prisoner” and called him a “Palestinian freedom fighter” in the headline.

These descriptors violated the Times’ own standards. In April, the Times published an op-ed by Marwan and identified him simply as “a Palestinian leader and parliamentarian.” In the op-ed, Marwan made no mention of his multiple murder convictions and called the proceedings against him a “political show trial.”

After an uproar, the public editor of the Times agreed that Marwan was not properly identified and that the omissions damaged the paper’s credibility. The Times later added an editors’ note to the op-ed detailing his convictions.

Foundation Invests $7 Million in 8 Joint U.S.-Israel Business Ventures< /strong>

The Israel-US Binational Industrial Research and Development (BIRD) Foundation has approved $7 million in funding for eight new projects between American and Israeli companies.

The eight projects approved by the Board of Governors are in addition to the 940 projects that the BIRD Foundation has approved for funding during its 40-year history.

The new projects approved include: Atvio (Nesher, Israel) and Secant Group (Telford, PA): 3D culture platform of therapeutic cells manufactured using advanced biomaterials; C4 Systems (Tel Aviv, Israel) and Churchill Navigation (Boulder, CO): Airborne AR Mission System for First Responders; Check-Cap (Isfiya, Israel) and GE Healthcare (Marlborough, MA): Development of C-Scan colon cancer screening system for high volume manufacturing; Isorad (Yavne, Israel) and Synrad (Mukilteo, WA) development of new laser technologies for industrial applications; Melodea (Rehovot, Israel) and ICL Performance Products (St. Louis, MO): Development of Cellulose Nanocrystal (CNC) based formulations for innovative environmentally friendly architectural and industrial water-based coatings; Nutrino Health (Tel Aviv, Israel) and Welltok (Denver, CO): Creation of personalized nutrition recommendations for employers and health plans to support consumers in their daily lives; OpSys Technologies (Holon, Israel) and sdPhotonics (Orlando, FL): Innovative development of solid-state miniature Lidar sensors for autonomous vehicles; and Pill Tracker (Tel Aviv, Israel) and Target Health (New York, NY): Medication Tracking – Drug Compliance Save Lives.

The BIRD Foundation promotes collaboration between US and Israeli companies in different technological fields. To date, BIRD’s total investment in joint projects has been about $340 million, helping to generate direct and indirect sales of more than $10 billion.

(via Israel21c)

Be the first to comment

Please check your e-mail for a link to activate your account.